Literature DB >> 18255129

PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia.

Massimiliano Fambrini1, Carlo Penna, Annalisa Pieralli, Cecilia Bussani, Maria Grazia Fallani, Karin L Andersson, Gianfranco Scarselli, Mauro Marchionni.   

Abstract

OBJECTIVE: To compare the PCR detection rates of high risk human papillomavirus DNA in self-collected urine and cervical scrapes during follow-up of patients treated for HG-CIN by laser CO2 conization. PATIENTS AND METHODS: 52 women who submitted to laser conization for HG-CIN were enrolled into this prospective follow-up study receiving liquid-based cytology and HR-HPV testing by PCR assay on self-collected urine and cervical scrapes before and at 3, 6 and 12 months after treatment. Diagnostic accuracy and predictive values for treatment failure were evaluated for both urinary and cervical HPV testing and follow-up cytology.
RESULTS: 3 cases (5.8%) of recurrent HG-CIN occurred during follow-up. Positive margins and HR-HPV persistence resulted to significant risk factors for recurrence (p=0.01). The overall concordance on HR-HPV detection between paired urine and cervical samples was 96.6% and discord trend between agreement rates during follow-up were excluded by overall fixed-effect index (OR 1.03; 95% CI 0.62-1.70). No difference was observed comparing the three- and six-month cumulative sensitivity and NPV for recurrent disease of urinary and cervical HPV detections, with an increase of 5.6% in specificity associated with urinary testing.
CONCLUSIONS: PCR detection of HR-HPV in paired urine and cervical samples during follow-up revealed an excellent concordance, suggesting a potential equivalent role of the two methods within post-treatment follow-up. In our experience HPV testing on self-collected urine was more sensitive than cytology and more specific than cervical HPV detection to predict treatment failure. Larger studies are needed to definitively establish the role of urine-based HPV testing during follow-up.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18255129     DOI: 10.1016/j.ygyno.2007.12.032

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

Review 1.  Detection of human papillomavirus DNA in urine. A review of the literature.

Authors:  A Vorsters; I Micalessi; J Bilcke; M Ieven; J Bogers; P Van Damme
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-05       Impact factor: 3.267

2.  Accuracy of urinary human papillomavirus testing for the presence of cervical human papillomaviruses and higher grades of cervical intraepithelial neoplasia.

Authors:  Chandrika J Piyathilake; Suguna Badiga; Michelle M Chambers; Ilene K Brill; Roland Matthews; Edward E Partridge
Journal:  Cancer       Date:  2016-05-31       Impact factor: 6.860

Review 3.  The incidence of human papillomavirus infection following treatment for cervical neoplasia: a systematic review.

Authors:  Anne F Rositch; Heidi M Soeters; Tabatha N Offutt-Powell; Bradford S Wheeler; Sylvia M Taylor; Jennifer S Smith
Journal:  Gynecol Oncol       Date:  2014-01-07       Impact factor: 5.482

Review 4.  Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): A systematic review.

Authors:  Sarah R Hoffman; Tam Le; Alexandre Lockhart; Ayodeji Sanusi; Leila Dal Santo; Meagan Davis; Dana A McKinney; Meagan Brown; Charles Poole; Corinne Willame; Jennifer S Smith
Journal:  Int J Cancer       Date:  2017-02-27       Impact factor: 7.396

5.  Urine-based human papillomavirus DNA testing as a screening tool for cervical cancer in high-risk women.

Authors:  Keimari Mendez; Josefina Romaguera; Ana P Ortiz; Mariel López; Martin Steinau; Elizabeth R Unger
Journal:  Int J Gynaecol Obstet       Date:  2013-11-01       Impact factor: 3.561

6.  Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic.

Authors:  Vikrant V Sahasrabuddhe; Patti E Gravitt; S Terence Dunn; David Brown; Richard A Allen; Yolanda J Eby; Katie Smith; Rosemary E Zuna; Roy R Zhang; Michael A Gold; Mark Schiffman; Joan L Walker; Philip E Castle; Nicolas Wentzensen
Journal:  J Clin Microbiol       Date:  2013-11-06       Impact factor: 5.948

7.  Test Accuracy of Human Papillomavirus in Urine for Detection of Cervical Intraepithelial Neoplasia.

Authors:  Eliane Rohner; Lisa Rahangdale; Busola Sanusi; Andrea K Knittel; Laurence Vaughan; Kirsty Chesko; Brian Faherty; Samantha E Tulenko; John W Schmitt; LaHoma S Romocki; Vijay Sivaraman; Julie A E Nelson; Jennifer S Smith
Journal:  J Clin Microbiol       Date:  2020-02-24       Impact factor: 5.948

8.  The use of urine in the follow-up of HPV vaccine trials.

Authors:  Alex Vorsters; Severien Van Keer; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 9.  Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis.

Authors:  Neha Pathak; Julie Dodds; Javier Zamora; Khalid Khan
Journal:  BMJ       Date:  2014-09-16

10.  Self-sampling for high-risk human papillomavirus as a follow-up alternative after treatment of high-grade cervical intraepithelial neoplasia.

Authors:  Ellinor Östensson; Karen Belkić; Torbjörn Ramqvist; Miriam Mints; Sonia Andersson
Journal:  Oncol Lett       Date:  2021-01-31       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.